D-0784-2021 Class III Terminated
FDA drug recall D-0784-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on August 20, 2021 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated April 5, 2022). Affected quantity: 14,544 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- September 8, 2021
- Initiation Date
- August 20, 2021
- Termination Date
- April 5, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,544 bottles
Product Description
Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90
Reason for Recall
Subpotent
Distribution Pattern
Product was distributed nationwide.
Code Information
Lot # DN120006A, exp. date 12/2021